Table 1

Clinical characteristics of participants with type 2 diabetes

Number of participants908
Gender (male/female)565/343
Age (years)61 (53–67)
Diabetes duration (years)12 (6–17)
BMI (kg/m2)24.89±3.62
MSG (mmol/L)8.99 (7.79–10.45)
MPSG (mmol/L)10.05 (8.36–11.83)
TOR (%)0.34 (0.15–0.55)
TIR (%)0.66 (0.45–0.85)
SDSG (mmol/L)2.27 (1.60–3.04)
CV (%)24.79 (18.80–31.92)
LAGE (mmol/L)9.20 (6.70–11.90)
M value36.97 (32.41–42.23)
MAGE (mmol/L)5.58 (3.99–7.60)
J index41.56 (30.06–58.45)
HBGI6.38 (3.26–11.10)
LI2.50 (1.48–3.79)
ADRR218.11 (193.01–242.54)
  • Normally distributed variables are presented as mean±SD, and non-normally distributed data are expressed as median with IQR.

  • ADRR, average daily risk range; BMI, body mass index; CV, coefficient of variation; GRADE, glycemic risk assessment diabetes equation; HBGI, high blood glucose index; LAGE, largest amplitude of glycemic excursions; LI, liability index; MAGE, mean amplitude of glycemic excursions; MPSG, mean postprandial sensor glucose; MSG, mean sensor glucose; SDSG, SD of the sensor glucose; TIR, percentage of values within the target range (3.9–10 mmol/L); TOR, percentage of values out of the target range (<3.9 mmol/L or >10 mmol/L).